Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 271

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis

Open access
Dulak, Austin M., Schumacher, Steven E., van Lieshout, Jasper, Imamura, Yu, Fox, Cameron, Shim, Byoungyong, Ramos, Alex H., Saksena, Gordon, Baca, Sylvan C., Baselga, Jose, Tabernero, Josep, Barretina, Jordi, Enzinger, Peter C., Corso, Giovanni, Roviello, Franco, Lin, Lin, Bandla, Santhoshi, Luketich, James D., Pennathur, Arjun, Meyerson, Matthew, Ogino, Shuji, Shivdasani, Ramesh A., Beer, David G., Godfrey, Tony E., Beroukhim, Rameen, Bass, Adam J.·2012·Cancer Research

Abstract

A more detailed understanding of the somatic genetic events that drive gastrointestinal adenocarcinomas is necessary to improve diagnosis and therapy. Using data from high-density genomic profiling arrays, we conducted an analysis of somatic copy-number aberrations in 486 gastrointestinal adenocarcinomas including 296 esophageal and gastric cancers. Focal amplifications were substantially more prevalent in gastric/esophageal adenocarcinomas than colorectal tumors. We identified 64 regions of significant recurrent amplification and deletion, some shared and others unique to the adenocarcinoma types examined. Amplified genes were noted in 37% of gastric/esophageal tumors, including in therapeutically targetable kinases such as ERBB2, FGFR1, FGFR2, EGFR, and MET, suggesting the potential use of genomic amplifications as biomarkers to guide therapy of gastric and esophageal cancers where targeted therapeutics have been less developed compared with colorectal cancers. Amplified loci implicated genes with known involvement in carcinogenesis but also pointed to regions harboring potentially novel cancer genes, including a recurrent deletion found in 15% of esophageal tumors where the Runt transcription factor subunit RUNX1 was implicated, including by functional experiments in tissue culture. Together, our results defined genomic features that were common and distinct to various gut-derived adenocarcinomas, potentially informing novel opportunities for targeted therapeutic interventions. Cancer Res; 72(17); 4383–93. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-3893

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 271

Metadata

Authors
Dulak, A. M., Schumacher, S. E., van Lieshout, J., Imamura, Y., Fox, C., Shim, B., Ramos, A. H., Saksena, G., Baca, S. C., Baselga, J., Tabernero, J., Barretina, J., Enzinger, P. C., Corso, G., Roviello, F., Lin, L., Bandla, S., Luketich, J. D., Pennathur, A., Meyerson, M., Ogino, S., Shivdasani, R. A., Beer, D. G., Godfrey, T. E., Beroukhim, R., & Bass, A. J.
Venue
Cancer Research
Published
2012-08-30
Volume
72
Issue
17
Pages
4383-4393
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2074478596
Cited by
271
References
46
FWCI
9.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-3893
The paper
Dulak, A. M., Schumacher, S. E., van Lieshout, J., Imamura, Y., Fox, C., Shim, B., Ramos, A. H., Saksena, G., Baca, S. C., Baselga, J., Tabernero, J., Barretina, J., Enzinger, P. C., Corso, G., Roviello, F., Lin, L., Bandla, S., Luketich, J. D., Pennathur, A., . . . Bass, A. J. (2012). Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-3893

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.